(Alliance News) - RTW Biotech Opportunities Ltd said on Friday said it is participating in a EUR65 million Series A financing round for Alesta Therapeutics BV, a Leiden, Netherlands-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback